ECCR 2019
ECCR 2019: 22nd Meeting of the European Council for Cardiovascular Research (ECCR) 4 – 6 October 2019 Theme: Hypertension and Cardiometabolic Disease 
Park Hotel Villa Fiorita – Via Giovannie XXIII, 1 31050 Monastier di Treviso Aims The 22nd Meeting of the ECCR focused on recent advances in hypertension and cardiometabolic disease with an emphasis on translational research from discovery science to human disease. Highlights of the 22nd Meeting
- The programme included state-of-the art lectures by keynote speakers, training sessions, workshops and abstract sessions with dedicated time for trainees and new investigators.
- Special awards were given to trainees and fellows
- There were many social activities and networking opportunities
Programme outline An exciting and comprehensive programme that covered major topics in the field including:
- Vascular, endocrine and renal mechanisms in hypertension
- Vascular biology and pathophysiology
- Vascular aging, senescence and angiogenesis
- Adipose biology and cardiometabolic disease
- Vascular-associated systems – lymphatics and the blood brain barrier
- Obesity, metabolic disorders and cardiovascular disease
Hypertension and cardiometabolic disorders Day 1: 14.30-18.30
| 14.30-14.45 | Welcome and opening |
| 14.45-15.45 | Session 1. Mechanistic insights of vascular pathways in hypertension and small vessel disease |
| 14.45-15.15 | Overview and objectives of MINDSHIFT |
| Thomas Unger, CARIM, Maastricht, The Netherlands | |
| 15.15-15.45 | Vascular smooth muscle cell heterogeneity |
| Patrick Lacolley, Université de Lorraine, Nancy, France | |
| 15.45-16.15 | Microglia in cerebral small vessel disease: impact of hypertension and cardiometabolic disease |
| Sebastian Foulquier, Maastricht University, The Netherlands | |
| 16.15-16.30 | Refreshments |
| 16.30-17.30 | Session 2. The renin-angiotensin-aldosterone system revisited |
| 16.30-17.15 | 3 Abstract presentations |
| Young investigators | |
| 17.15-17.45 | Hyperaldosteronism |
| Gianpaolo Rossi, University of Padua, Italy | |
| 17.45-18.15 | RAAS profiling in Health and Disease |
| Marko Poglitsch, Attoquant Diagnostics GmbH, Vienna, Austria | |
| 18.15-18.45 | Beyond the classical RAAS |
| Muscha Steckelings, Odense University, Denmark | |
| 19.30 | Dinner and fun evening |
Day 2: 07.30-18.00
| 07.30-8.30 | Early Career Scientists Workshop I. |
| Career planning, networking, grant writing and publishing –everything you wanted to know about succeeding | |
| Rhian Touyz, University of Glasgow, United Kingdom | |
| 08.45-10.15 | Session 3. Vessels beyond hypertension |
| 8.45-09.15 | Endothelial and vascular smooth muscle genomic instability and cardiovascular disease |
| Anton Roks, Erasmus University, Rotterdam, The Netherlands | |
| 09.15-09.45 | Angiogenesis, VEGF inhibitors and hypertension |
| Jan Danser, Erasmus University, Rotterdam, The Netherlands | |
| 09.45-10.15 | The Contrasting Role of Nox4 and Nox5 in Hypertension |
| Augusto Montezano, University of Glasgow, United Kingdom | |
| 10.15-10.45 | Refreshments |
| 10.45-16.30 | Session 4. Vascular biology and pathophysiology |
| 10.45 11.45 | 4 Abstract presentations |
| Young investigators | |
| 11.45-12.15 | Microvascular dysfunction, hyperglycemia and chronic diseases |
| Coen Stehouwer, Maastricht University, The Netherlands | |
| 12.15-12.45 | An update on estrogen and cardiovascular disease |
| Matthius Barton, University of Zurich, Switzerland | |
| 13.15-15.30 | Lunch and posters |
| 15.30-16.30 | Session 4. Vascular biology and pathophysiology (continued) |
| 15.30-16.00 | Vascular phenotyping in hypertension- preclinical and clinical |
| Christian Delles, University of Glasgow, United Kingdom | |
| 16.00-16.30 | Vascular remodeling of resistance arteries in hypertension |
| Agostino Virdis, Università di Pisa, Italy | |
| 16.30- 17.30 | Session 5. Adipose biology and cardiometabolic disease |
| 16.30-17.00 | Perivascular adipose tissue and vascular reactivity |
| Damiano Rizzoni, University of Brescia, Italy | |
| 17.00-17.30 | Targeting the renin angiotensin system in cardio-metabolic disease |
| Ludovit Paulis, Comenius University, Bratislava, Slovakia | |
| 17.30-18.00 | AGM/BUSINESS MEETING |
| 19.30 | Gala Dinner and fun evening |
Day 3: 07.30-13.30
|
07.30-08.30 |
Early Career Scientists Workshop II |
| 08.45- 10.45 | Session 6. Obesity, metabolic disorders and cardiovascular disease- mechanisms and clinical implications |
| 08.45-09.15 | Nitric oxide, vascular inflammation and obesity |
| Olga Pechánová, Slovak Academy of Sciences, Bratislava, Slovakia | |
| 09.15-09.45 | Caloric restriction, oxidative stress and obesity |
| Marta Gill-Ortega University of Madrid, Spain | |
| 09.45-10.15 | Anorexigenic peptides, obesity and chronic diseases |
| Lenka Maletinska, Institute of Organic Chemistry and Biochemistry AS CR, Prague, Czech Republic | |
| 09.45-10.15 | SGL2 inhibitor anti-diabetic drugs and cardiovascular disease |
| Carmine Savoia, Sapienza University, Italy | |
| 10.45-11.15 | Refreshments |
| 11.15-13.15 | Session 7. Vascular-associated systems: Lymphatics, and the blood brain barrier |
| 11.15-11.45 | 2 Abstract presentations |
| Young investigators | |
| 11.45-12.15 | Lymphatics, skin and salt homeostasis-new paradigms |
| Giacomo Rossitto, University of Padua, Italy | |
| 12.15-12.45 | Microvascular dysfunction and small vessel disease of the brain |
| Boy Houben, Maastricht University, The Netherlands | |
| 12.45-13.15 | Bone marrow microvascular dysfunction in metabolic disease and ischemia. |
| Paolo Madeddu, Bristol Heart Institute, University of Bristol, United Kingdom | |
| 13.15-13.30 | Closing ceremony and awards |
| 13.30-14.30 | Lunch |
| Departure |
